2021
DOI: 10.1186/s12974-021-02098-y
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptome profiling of long noncoding RNAs and mRNAs in spinal cord of a rat model of paclitaxel-induced peripheral neuropathy identifies potential mechanisms mediating neuroinflammation and pain

Abstract: Background Paclitaxel is a widely prescribed chemotherapy drug for treating solid tumors. However, paclitaxel-induced peripheral neuropathy (PIPN) is a common adverse effect during paclitaxel treatment, which results in sensory abnormalities and neuropathic pain among patients. Unfortunately, the mechanisms underlying PIPN still remain poorly understood. Long noncoding RNAs (lncRNAs) are novel and promising targets for chronic pain treatment, but their involvement in PIPN still remains unexplor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
29
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 42 publications
(35 citation statements)
references
References 76 publications
(62 reference statements)
6
29
0
Order By: Relevance
“…The number of ATF3 + neurons were significantly higher in the DRG of paclitaxel-treated animals indicating damage; however, there were no sex-based or genotype differences observed (Figure 6 and Table 5). The increase is similar to previously published literature, albeit at a later time point (59,60), thus we conclude that this higher dose does not comparatively alter DRG neurons at day 10 after our regimen. (61)(62)(63).…”
Section: Sensory Neuron Damage By Paclitaxel Is Similar For Both Sexes and Genotypessupporting
confidence: 91%
“…The number of ATF3 + neurons were significantly higher in the DRG of paclitaxel-treated animals indicating damage; however, there were no sex-based or genotype differences observed (Figure 6 and Table 5). The increase is similar to previously published literature, albeit at a later time point (59,60), thus we conclude that this higher dose does not comparatively alter DRG neurons at day 10 after our regimen. (61)(62)(63).…”
Section: Sensory Neuron Damage By Paclitaxel Is Similar For Both Sexes and Genotypessupporting
confidence: 91%
“…For positive control, in one of our recent studies, we stained DRGs with ATF3 from paclitaxel-treated rats, a rat model for chemotherapy-induced peripheral neuropathy and well known for its peripheral neuropathy. We found the number of ATF3 positively expressed neurons was signi cantly increased in DRG of paclitaxel-treated rats vs. control rats [32]. Therefore, the above results indicated no neuronal damage occurred in bilateral DRG neurons of the CPIP model rats.…”
Section: Pathological Evaluation Of Ipsilateral and Contralateral Drg Neurons Innervating The Hind Pawssupporting
confidence: 51%
“…Increasing evidence has shown that lncRNAs are involved in multiple biological and pathological processes, including neurodegenerative disease [ 18 , 19 ]. LncRNAs can regulate microglia/macrophage polarization and innate immune responses [ 20 , 21 ]. A recent study demonstrated that lncRNA Tug1 could regulate PGC-1伪 expression in mitochondrial bioenergetics [ 22 ].…”
Section: Introductionmentioning
confidence: 99%